You are here: Industry Insights > Sanofi

News List

Real world data back Sanofi’s Toujeo for type I diabetes pharmatimes
March 21, 2018
Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients with type I diabetes.
Sanofi and Regeneron Slash Cost of New Cholesterol Drug Praluent biospace
March 13, 2018
One of the reasons the new class of cholesterol-lowering medications, PCSK9 inhibitors, have had trouble gaining traction in the marketplace is because of cost
Sanofi in talks with Evotec to out-licence antibiotic research pharmaphorum
March 12, 2018
Sanofi is in talks with the German biotech Evotec to out-license most of its infectious disease R&D, including novel antimicrobial research.
EvoTec to command vast Sanofi resources in infectious disease R&D partnership pharmafile
March 09, 2018
Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation platform in the research and development of new treatments for infectious diseases.
Evotec and Sanofi Collaborate on Infectious Disease R&D Initiative biospace
March 09, 2018
Sanofi Pasteur and Germany-based Evotec AG have teamed up to form an infectious disease research and development program in Lyon, France.
FDA to review Sanofi’s Dupixent in asthma pharmaphorum
March 06, 2018
The FDA is to review Sanofi/Regeneron’s Dupixent as a treatment for asthma, a new use that could more than double its sales following its previous approval for eczema.
Sanofi files Dupixent for severe asthma pharmatimes
March 05, 2018
US regulators have accepted for review Sanofi/Regeneron’s biologic Dupixent as an add-on maintenance treatment in certain adults and adolescents with moderate-to-severe asthma.
Sanofi and Regeneron Seek FDA Approval of Dupixent as Add-On Asthma Therapy biospace
March 05, 2018
Asthma patients may soon have a new treatment option.
Preliminary report outlines 'causal association' between Sanofi's Dengvaxia and 3 deaths fiercepharma
February 05, 2018
After months of controversy in the Philippines over Sanofi's Dengvaxia, an initial report has found a "causal association" between three deaths and the vaccine. Two of the deaths could have been a result of vaccine failure, according to the Philippine Gen
Sanofi, DNDi seek EMA review for sleeping sickness drug pharmatimes
February 02, 2018
Sanofi has asked European regulators to review an experimental medicine being developed in partnership with the Drugs for Neglected Disease initiative (DNDi) for sleeping sickness, which is endemic in Africa.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page